Acetazolamide sensitive tissue calcification and aging of klotho-hypomorphic mice

[1]  Mahboob Rahman,et al.  Current status of bicarbonate in CKD. , 2015, Journal of the American Society of Nephrology : JASN.

[2]  E. Schleicher,et al.  NH4Cl Treatment Prevents Tissue Calcification in Klotho Deficiency. , 2015, Journal of the American Society of Nephrology : JASN.

[3]  M. Rattazzi,et al.  Osteoprotegerin in cardiovascular disease: ally or enemy? , 2014, Current pharmaceutical design.

[4]  N. Powe,et al.  Biomarkers of vascular calcification and mortality in patients with ESRD. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[5]  M. Rosenfeld,et al.  Increased Calcification in Osteoprotegerin-Deficient Smooth Muscle Cells: Dependence on Receptor Activator of NF-κB Ligand and Interleukin 6 , 2014, Journal of Vascular Research.

[6]  I. Łoniewski,et al.  Bicarbonate therapy for prevention of chronic kidney disease progression. , 2014, Kidney international.

[7]  C. Liapis,et al.  Serum Levels of Fetuin-A, Osteoprotegerin and Osteopontin in Patients with Coronary Artery Disease: Effects of Statin (HMGCoA-Reductase Inhibitor) Therapy , 2014, Clinical Drug Investigation.

[8]  S. Kato,et al.  Functional Cooperation between Vitamin D Receptor and Runx2 in Vitamin D-Induced Vascular Calcification , 2013, PloS one.

[9]  E. Schleicher,et al.  Effect of Carbon Monoxide Donor CORM-2 on Vitamin D3 Metabolism , 2013, Kidney and Blood Pressure Research.

[10]  M. Kuro-o.  Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism , 2013, Nature Reviews Nephrology.

[11]  A. Togari,et al.  Acidosis Inhibits Mineralization in Human Osteoblasts , 2013, Calcified Tissue International.

[12]  K. Rosenblatt,et al.  Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice. , 2013, The Journal of clinical investigation.

[13]  B. Lanske,et al.  Deletion of PTH Rescues Skeletal Abnormalities and High Osteopontin Levels in Klotho −/− Mice , 2012, PLoS genetics.

[14]  K. Rosenblatt,et al.  Hyperaldosteronism in Klotho-deficient mice. , 2010, American journal of physiology. Renal physiology.

[15]  K. Rosenblatt,et al.  Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  K. Kalantar-Zadeh,et al.  Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. , 2010, Kidney international. Supplement.

[17]  M. McKee,et al.  Molecular determinants of extracellular matrix mineralization in bone and blood vessels , 2010, Current opinion in nephrology and hypertension.

[18]  R. Villa-Bellosta,et al.  Compensatory regulation of the sodium/phosphate cotransporters NaPi-IIc (SCL34A3) and Pit-2 (SLC20A2) during Pi deprivation and acidosis , 2010, Pflügers Archiv - European Journal of Physiology.

[19]  J. Hoenderop,et al.  Klotho prevents renal calcium loss. , 2009, Journal of the American Society of Nephrology : JASN.

[20]  C. Giachelli,et al.  The role of osteopontin in inflammatory processes , 2009, Journal of Cell Communication and Signaling.

[21]  D. Yonova.  Vascular calcification and metabolic acidosis in end stage renal disease. , 2009, Hippokratia.

[22]  H. Murer,et al.  Regulation of phosphate transport in proximal tubules , 2009, Pflügers Archiv - European Journal of Physiology.

[23]  C. Shanahan,et al.  Targeting vascular calcification: softening-up a hard target. , 2009, Current opinion in pharmacology.

[24]  F. J. Mendoza,et al.  Metabolic acidosis inhibits soft tissue calcification in uremic rats. , 2008, Kidney international.

[25]  J. Hoenderop,et al.  Regulation of the epithelial calcium channel TRPV5 by extracellular factors , 2007, Current opinion in nephrology and hypertension.

[26]  Shinzo Tanaka,et al.  α-Klotho as a Regulator of Calcium Homeostasis , 2007, Science.

[27]  D. Leaf,et al.  Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness. , 2007, Journal of applied physiology.

[28]  Y. Nabeshima,et al.  Correlation between hyperphosphatemia and type II Na-Pi cotransporter activity in klotho mice. , 2007, American journal of physiology. Renal physiology.

[29]  R. Rajatanavin,et al.  Chronic metabolic acidosis alters osteoblast differentiation from human mesenchymal stem cells. , 2007, Kidney international.

[30]  I. Ramasamy.  Recent advances in physiological calcium homeostasis , 2006, Clinical chemistry and laboratory medicine.

[31]  J. Hoenderop,et al.  Acid-base status determines the renal expression of Ca2+ and Mg2+ transport proteins. , 2006, Journal of the American Society of Nephrology : JASN.

[32]  J. Coladonato,et al.  Control of hyperphosphatemia among patients with ESRD. , 2005, Journal of the American Society of Nephrology : JASN.

[33]  Animesh Nandi,et al.  Suppression of Aging in Mice by the Hormone Klotho , 2005, Science.

[34]  T. Arnett,et al.  Acidosis Inhibits Bone Formation by Osteoblasts In Vitro by Preventing Mineralization , 2005, Calcified Tissue International.

[35]  A. Valdivieso,et al.  Effect of ammonium chloride and dietary phosphorus in the azotaemic rat. I. Renal function and biochemical changes. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[36]  K. Nozaki,et al.  Secreted Klotho protein in sera and CSF: implication for post‐translational cleavage in release of Klotho protein from cell membrane , 2004, FEBS letters.

[37]  K. Fukuda,et al.  Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. , 2003, Molecular endocrinology.

[38]  C. Kleeman,et al.  Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease. , 2000, Kidney international.

[39]  M. Kuro-o,et al.  Cellular and molecular mechanism of low-turnover osteopenia in the klotho-deficient mouse , 2000, Cellular and Molecular Life Sciences CMLS.

[40]  D. Bushinsky,et al.  In vitro metabolic and respiratory acidosis selectively inhibit osteoblastic matrix gene expression. , 1999, American journal of physiology. Renal physiology.

[41]  M. Levi,et al.  Regulation of renal phosphate transport by acute and chronic metabolic acidosis in the rat. , 1998, Kidney international.

[42]  Tadashi Kaname,et al.  Mutation of the mouse klotho gene leads to a syndrome resembling ageing , 1997, Nature.

[43]  W. L. Peter,et al.  Acetazolamide Toxicity and Pharmacokinetics in Patients Receiving Hemodialysis , 1995, Pharmacotherapy.

[44]  V. Torres,et al.  Renal cystic disease and ammoniagenesis in Han:SPRD rats. , 1994, Journal of the American Society of Nephrology : JASN.

[45]  E. Cecchin,et al.  Severe metabolic acidosis and disturbances of calcium metabolism induced by acetazolamide in patients on haemodialysis. , 1990, Clinical science.

[46]  N. Bell,et al.  Effects of acetazolamide on the renal excretion of phosphate in hypoparathyroidism and pseudohypoparathyroidism. , 1977, The Journal of laboratory and clinical medicine.

[47]  G. Eknoyan,et al.  Effect of diuretics on urinary excretion of phosphate, calcium, and magnesium in thyroparathyroidectomized dogs. , 1970, The Journal of laboratory and clinical medicine.

[48]  R. Garrick.  Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease , 2011 .

[49]  L. Quintanilla‐Martinez,et al.  Standardized morphological phenotyping of mouse models of human diseases within the German Mouse Clinic. , 2007, Verhandlungen der Deutschen Gesellschaft fur Pathologie.

[50]  L. Demer,et al.  Regulatory mechanisms in vascular calcification. , 2000, Critical reviews in eukaryotic gene expression.